Ginette 35 Tablet

Ginette 35 Tablet is helpful in treating androgen-dependent diseases such as polycystic ovarian syndrome (PCOS), excessive hair growth (hirsutism), acne and irregular periods. It is a combination of cyproterone and ethinyl estradiol.

The tablet works by preventing the overproduction of androgens in the ovaries of female, due to which unwanted hair growth and acne is reduced. The dose of the medicine should be taken as prescribed by the doctor. It can be taken with or without food but it is important to take it as a fixed time.

Take according to recommended schedule. It is important to maintain schedule of drug days and drug-free days. Periodic gynecologic exam and breast exams for females are important.

You may experience nausea or vomiting (small frequent meals may help); dizziness or mental depression (use caution when driving); rash; loss of scalp hair; enlargement/tenderness of breasts; or increased/decreased libido.

Report significant swelling in extremities, sudden acute pain in legs or calves, chest, or abdomen; shortness of breath; severe headache or vomiting; weakness or numbness of arms or legs; or unusual vaginal bleeding.

Also Read: Diominic DCA Tablet Uses

• Polycystic Ovary Syndrome (Pcos)

• Acne

• Hirsutism

• Allergy

• Undiagnosed Vaginal Bleeding

• Thrombophlebitis

• Pregnancy

• Nausea Or Vomiting

• Headache

• Rapid Weight Gain

• Breast Pain

• Abdominal Pain

• Diarrhoea

• Peripheral Edema

• Bloating

• Increased Libido

• Thromboembolism

• Stroke

• Depression

• Dizziness

• Anxiety

• Are there any pregnancy warnings?

  Ginette 35 Tablet is highly unsafe to use during pregnancy.

• Are there any breast-feeding warnings?

  Ginette 35 Tablet is probably safe to use during breastfeeding. Please consult your doctor.

• Is it safe to drive while on this medicine?

  There is no data available. Please consult doctor before consuming the drug.

• Does this affect kidney function?

  There is no interaction between renal impairment and consuming this drug. So dose alteration is not needed.

• Does this affect liver function?

  Mild to moderate liver impairment: Dosage reduction of estrogens is recommended. In Severe liver impairment: Not recommended.

Below is the list of medicines, which have the same composition, strength and form as Ginette 35 Tablet , and hence can be used as its substitute.

• Carpela 0.035 Mg/2 Mg Tablet

  Eris Life Sciences Pvt Ltd

• ESTRANON TABLET

  Organon (India) Ltd

• Diane 35 Tablet

  Zydus Cadila

• Krimson 35 Tablet

  Sun Pharmaceutical Industries Ltd

• Elestra 0.035 Mg/2 Mg Tablet

  Macleods Pharmaceuticals Pvt Ltd

• Butipil 0.035 Mg/2 Mg Tablet

  Sanzyme Ltd

• Carrol 0.035 Mg/2 Mg Tablet

  Alembic Pharmaceuticals Ltd

• Hersuit 0.035 Mg/2 Mg Tablet

  Eskag Pharma Pvt Ltd

• Evashine 0.035 Mg/2 Mg Tablet

  Celon Laboratories Ltd

• Herface 0.035 Mg/2 Mg Tablet

  Torrent Pharmaceuticals Ltd

• Are there any missed dose instructions?

  If you miss a dose, skip it and continue with your normal schedule. Do not double the dose.

• Are there any overdose instructions?

  Consult a doctor in case of an overdose.

The drug prevents the binding of dihydrotestosterone into the receptors, located at the prostatic carcinoma cell. It also enters the cells and binds to the estrogen receptors and forms a complex that enters the cell nucleus and bind to the DNA. This activates the DNA transcription of genes that are involved in estrogenic cellular responses.

Whenever you take more than one medicine, or mix it with certain foods or beverages, you"re at risk of a drug interaction.

test

• Interaction with Lab Test

  • Decreased antithrombin III
  • Decreased serum folate concentration
  • Increased prothrombin and factors VII, VIII, IX, X
  • Increased platelet aggregability
  • Increased thyroid binding globulin
  • Increased total thyroid hormone (T4)
  • Increased serum triglycerides/phospholipids

• Interaction with Medicine

  The drug interacts with ritonavir, nelfinavir, nevirapine, primidone, phenytoin, carbamazepine, oxcarbazepine, topiramate, griseofulvin and rifampicin.

• Interaction with Disease

  Use with caution in patients with asthma, seizure disorders, migraine, cardiac, renal or hepatic impairment, cerebrovascular disorders or history of breast cancer, past or present thromboembolic disease, smokers >35 years of age.

• Ques : What is Ginette 35 tablet?

  Ans : Ginette tablet is a medication which has cyproterone and ethinyl estradiol as active elements present in it.

• Ques : What is the use of ginette 35 tablet?

  Ans : Ginette is used for the treatment and prevention from conditions such as PCOS, hormone replacement therapy for transgender women, increased sex drive and pregnancy prevention.

• Ques : What are the side effects of Ginette 35 tablet?

  Ans : Ginette tablet causes side effects such as blood clot formation, nausea, amenorrhea, anaphylactic reactions, cervical erosion, etc.

• Ques : What are the instructions for storage and disposal Ginette 35 Tablet?

  Ans : Ginette should be kept in a cool dry place and in its original packaging. Make sure this medication remains unreachable to children and pets.

• Ques : What if I miss to take Ginette?

  Ans : If you miss a dose, you should take it as soon as possible. If the dose was missed by more than 12 hours, you should not take the missed dose and simply continue the usual schedule.

• Ques : How long do I need to use ginette 35 tablet before I see improvement of my conditions?

  Ans : This medication should be consumed, until the complete eradication of the disease. It is advised to use till the time directed by your doctor.

• Ques : At what frequency do I need to use ginette 35 tablet ?

  Ans : Ginette 35 Tablet is generally used once or twice a day, as the time interval up to which this medication has an impact is around 12 to 24 hours.

• Ques : Should I use ginette 35 tablet empty stomach, before food or after food?

  Ans : The action of salts involved in this medication does not depend on using it pre-meal or post-meal.

• Cyproterone- Drug Information Portal [Internet]. druginfo.nlm.nih.gov. 2019 [Cited 27 April 2019]. Available from:

  https://druginfo.nlm.nih.gov/drugportal/name/cyproterone

• Ethinylestradiol- Drug Information Portal [Internet]. druginfo.nlm.nih.gov. 2019 [Cited 24 April 2019]. Available from:

  https://druginfo.nlm.nih.gov/drugportal/name/ethinyl%20estradiol

• Ethinylestradiol- DrugBank [Internet]. Drugbank.ca. 2019 [Cited 15 May 2019]. Available from:

  https://www.drugbank.ca/drugs/DB00977